Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shi

Showing results (781-790 of 938) with videos related to

Pageof 94
Sort By:
Nature Communications|March 8, 2018
Direct observation of orbital hybridisation in a cuprate superconductorC E Matt, D Sutter, A M Cook, et al.
Blood|February 26, 2025
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHDYanmin M Zhao, Yi Luo, Jimin M Shi, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 29, 2026
[Association between urinary arsenic levels and neurological mortality in older adults aged 60 years and above in China]F Y Long, Y D Wu, Y L Qu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 12, 2017
[A multicenter, retrospective study of pathogenic bacteria distribution and drug resistance in febrile neutropenic patients with hematological diseases in Shanghai]J Zhu, J Hu, Y F Mao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Cell-surface proteomic profiling identifies CD72 as a regulator of microglial tilingTamara C Chan, Mohit Rastogi, Micah X Williams, et al.
Lancet (London, England)|January 16, 2026
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trialShun Lu, Jie Wang, Nong Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2020
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trialM Shi, A Gu, H Tu, et al.
JAMA Network Open|February 28, 2022
Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device ExpulsionMary Anne Armstrong, Tina Raine-Bennett, Susan D Reed, et al.
American Journal of Obstetrics and Gynecology|April 8, 2022
Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device studyJennifer L Gatz, Mary Anne Armstrong, Debbie Postlethwaite, et al.
American Journal of Obstetrics and Gynecology|March 16, 2022
Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device studyDarios Getahun, Michael J Fassett, Jennifer Gatz, et al.
Pageof 94

Showing results (781-790 of 938) with videos related to

Sort By:
Pageof 94
Nature Communications|March 8, 2018
Direct observation of orbital hybridisation in a cuprate superconductorC E Matt, D Sutter, A M Cook, et al.
Blood|February 26, 2025
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHDYanmin M Zhao, Yi Luo, Jimin M Shi, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 29, 2026
[Association between urinary arsenic levels and neurological mortality in older adults aged 60 years and above in China]F Y Long, Y D Wu, Y L Qu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 12, 2017
[A multicenter, retrospective study of pathogenic bacteria distribution and drug resistance in febrile neutropenic patients with hematological diseases in Shanghai]J Zhu, J Hu, Y F Mao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Cell-surface proteomic profiling identifies CD72 as a regulator of microglial tilingTamara C Chan, Mohit Rastogi, Micah X Williams, et al.
Lancet (London, England)|January 16, 2026
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trialShun Lu, Jie Wang, Nong Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2020
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trialM Shi, A Gu, H Tu, et al.
JAMA Network Open|February 28, 2022
Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device ExpulsionMary Anne Armstrong, Tina Raine-Bennett, Susan D Reed, et al.
American Journal of Obstetrics and Gynecology|April 8, 2022
Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device studyJennifer L Gatz, Mary Anne Armstrong, Debbie Postlethwaite, et al.
American Journal of Obstetrics and Gynecology|March 16, 2022
Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device studyDarios Getahun, Michael J Fassett, Jennifer Gatz, et al.
Pageof 94